Efficacy and safety of bevacizumab combined with chemotherapy in symptomatic brain metastases from lung adenocarcinoma: a retrospective analysis.

Zhan, Qiong; Miao, Feng; Huang, Ruofan; Zhou, Xinli; Ge, Mengxi; Liang, Xiaohua

Zhan, Qiong; Miao, Feng; Huang, Ruofan; Zhou, Xinli; Ge, Mengxi; Liang, Xiaohua.

Afiliação

Zhan Q; Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Miao F; Department of Thoracic Surgery, Huashan Hospital North, Fudan University, Shanghai 200040, China.
Huang R; Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Zhou X; Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Ge M; Department of Thoracic Surgery, Huashan Hospital North, Fudan University, Shanghai 200040, China.
Liang X; Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China.

J Thorac Dis ; 11(11): 4725-4734, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31903262

Palavras-chave

Symptomatic brain metastases; bevacizumab plus chemotherapy; lung adenocarcinoma; vascular endothelial growth factor (VEGF)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: J Thorac Dis Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google